Structure and property guided design in the identification of PRMT5 tool compound EPZ015666
ACS medicinal chemistry letters, 2016•ACS Publications
The recent publication of a potent and selective inhibitor of protein methyltransferase 5
(PRMT5) provides the scientific community with in vivo-active tool compound EPZ015666
(GSK3235025) to probe the underlying pharmacology of this key enzyme. Herein, we report
the design and optimization strategies employed on an initial hit compound with poor in vitro
clearance to yield in vivo tool compound EPZ015666 and an additional potent in vitro tool
molecule EPZ015866 (GSK3203591).
(PRMT5) provides the scientific community with in vivo-active tool compound EPZ015666
(GSK3235025) to probe the underlying pharmacology of this key enzyme. Herein, we report
the design and optimization strategies employed on an initial hit compound with poor in vitro
clearance to yield in vivo tool compound EPZ015666 and an additional potent in vitro tool
molecule EPZ015866 (GSK3203591).
The recent publication of a potent and selective inhibitor of protein methyltransferase 5 (PRMT5) provides the scientific community with in vivo-active tool compound EPZ015666 (GSK3235025) to probe the underlying pharmacology of this key enzyme. Herein, we report the design and optimization strategies employed on an initial hit compound with poor in vitro clearance to yield in vivo tool compound EPZ015666 and an additional potent in vitro tool molecule EPZ015866 (GSK3203591).
ACS Publications